pre-ipo
Stage
About
Aclara Biosciences developed microfluidics technology that automated genetic sequencing and other laboratory functions, and went public in 2000.
Explore Aclara Biosciences's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.